Maha FDA shortlists 59 pharmacists for selling Remdesivir
Mumbai: The Maharashtra government on Friday came out with a list of 59 pharmacists in the state where Remdesivir, a drug used for COVID-19 treatment, will be available at Rs 2,360 per unit.
Principal secretary of the public health department Dr Pradeep Vyas informed district collectors and municipal commissioners about the decision in a letter.
"The medicine is administered free of cost at state- run hospitals, however, there was no cap on its price at private hospitals.
"(Now) The pharmaceutical shops in every district and city are designated for its supply, which will ensure smooth supply of the medicine to every patient," Vyas said in the letter.
Read also: Gilead, European Commission Ink Pact For 500000 Treatment Courses Of Remdesivir Against COVID-19
"The Food and Drug Administration has shortlisted the pharmaceutical outlets in the state. There are five outlets in Mumbai division, 13 in Pune division, nine in Nashik, 11 in Aurangabad, 10 in Konkan, six in Nagpur and five in Amravati," the letter said.
Read also: FDA approves remdesivir for treating hospitalized COVID-19 patients
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.